Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lebrec

Showing results (251-260 of 353) with videos related to

Pageof 36
Sort By:
Gastroenterologie Clinique Et Biologique|August 1, 1989
[Relation between plasma catecholamines, the severity of the liver disease and hemodynamics in patients with cirrhosis]C Gaudin, A Braillon, R Moreau, et al.
European Journal of Pharmacology|September 19, 1996
Haemodynamic and hormonal responses to long-term inhibition of nitric oxide synthesis in rats with portal hypertensionC Pilette, R Moreau, P Sogni, et al.
Hepatology (Baltimore, Md.)|September 1, 1991
Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosisY Bacq, C Gaudin, A Hadengue, et al.
Digestive Diseases and Sciences|March 1, 1979
Gastrointestinal bleeding due to chronic portal vein thrombosis in ulcerative colitisJ P Capron, A Remond, D Lebrec, et al.
Liver|October 1, 1996
Systemic and splanchnic hemodynamic changes in patients with hepatic schistosomiasisC Denié, F Vachiery, A Elman, et al.
Scandinavian Journal of Gastroenterology|August 1, 1988
Comparative haemodynamic effects of betaxolol and propranolol in patients with cirrhosisA Braillon, S S Lee, D Valla, et al.
Nephron|January 1, 1993
Renal hemodynamics in patients with cirrhosis: relationship with ascites and liver failureR Moreau, C Gaudin, A Hadengue, et al.
The Journal of Laboratory and Clinical Medicine|December 1, 1986
Role of portasystemic shunts in the hyperkinetic circulation of the portal hypertensive ratA Braillon, S S Lee, C Girod, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1992
[Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis]R Moreau, O Soubrane, A Hadengue, et al.
Journal of Hepatology|October 1, 1987
Naloxone does not alter haemodynamics in cirrhosis. Studies in humans and ratsS S Lee, A Hadengue, R Moreau, et al.
Pageof 36

Showing results (251-260 of 353) with videos related to

Sort By:
Pageof 36
Gastroenterologie Clinique Et Biologique|August 1, 1989
[Relation between plasma catecholamines, the severity of the liver disease and hemodynamics in patients with cirrhosis]C Gaudin, A Braillon, R Moreau, et al.
European Journal of Pharmacology|September 19, 1996
Haemodynamic and hormonal responses to long-term inhibition of nitric oxide synthesis in rats with portal hypertensionC Pilette, R Moreau, P Sogni, et al.
Hepatology (Baltimore, Md.)|September 1, 1991
Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosisY Bacq, C Gaudin, A Hadengue, et al.
Digestive Diseases and Sciences|March 1, 1979
Gastrointestinal bleeding due to chronic portal vein thrombosis in ulcerative colitisJ P Capron, A Remond, D Lebrec, et al.
Liver|October 1, 1996
Systemic and splanchnic hemodynamic changes in patients with hepatic schistosomiasisC Denié, F Vachiery, A Elman, et al.
Scandinavian Journal of Gastroenterology|August 1, 1988
Comparative haemodynamic effects of betaxolol and propranolol in patients with cirrhosisA Braillon, S S Lee, D Valla, et al.
Nephron|January 1, 1993
Renal hemodynamics in patients with cirrhosis: relationship with ascites and liver failureR Moreau, C Gaudin, A Hadengue, et al.
The Journal of Laboratory and Clinical Medicine|December 1, 1986
Role of portasystemic shunts in the hyperkinetic circulation of the portal hypertensive ratA Braillon, S S Lee, C Girod, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1992
[Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis]R Moreau, O Soubrane, A Hadengue, et al.
Journal of Hepatology|October 1, 1987
Naloxone does not alter haemodynamics in cirrhosis. Studies in humans and ratsS S Lee, A Hadengue, R Moreau, et al.
Pageof 36